Latest filing published 26 Aug 2020 for Verrica Pharmaceuticals Inc., €41k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +23.8%Entry US$89.40 · Close at T+365 US$110.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Craig Ballaron: trading record in brief
Craig Ballaron discloses dealings in Verrica Pharmaceuticals Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 24 August 2020 to 25 August 2020.
Purchases make up the whole of the open-market record (2 purchases, €75k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 26 August 2020 with an open-market purchase (€41k) in Verrica Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Craig Ballaron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,228 shares@ US$9.1654.0% of flowCommon StockSEC:0001209191-20-048401:0Canonical exit: 22 Nov 2020 (T+90)
- 4,772 shares@ US$8.5746.0% of flowCommon StockSEC:0001209191-20-048401:1Canonical exit: 23 Nov 2020 (T+90)
2 of 2 declarations
